231 related articles for article (PubMed ID: 37012873)
1. Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson's disease in rats: Correlation between Nrf2 and HMGB1/TLR4/PI3K/Akt/mTOR signaling.
El-Sayed RM; Abdelaziz AM; Zaki HF; Abdel Rasheed NO
Int Immunopharmacol; 2023 Apr; 117():109986. PubMed ID: 37012873
[TBL] [Abstract][Full Text] [Related]
2. Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease.
Vasudevan Sajini D; Thaggikuppe Krishnamurthy P; Chakkittukandiyil A; Mudavath RN
Neurochem Res; 2024 Jun; 49(6):1577-1587. PubMed ID: 38276990
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of crocin against rotenone-induced Parkinson's disease in rats: Interplay between PI3K/Akt/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221.
Salama RM; Abdel-Latif GA; Abbas SS; El Magdoub HM; Schaalan MF
Neuropharmacology; 2020 Mar; 164():107900. PubMed ID: 31811872
[TBL] [Abstract][Full Text] [Related]
4. Agmatine-mediated inhibition of NMDA receptor expression and amelioration of dyskinesia via activation of Nrf2 and suppression of HMGB1/RAGE/TLR4/MYD88/NF-κB signaling cascade in rotenone lesioned rats.
Azar YO; Badawi GA; Zaki HF; Ibrahim SM
Life Sci; 2022 Dec; 311(Pt A):121049. PubMed ID: 36209830
[TBL] [Abstract][Full Text] [Related]
5. Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway.
Cui Q; Li X; Zhu H
Mol Med Rep; 2016 Feb; 13(2):1381-8. PubMed ID: 26648392
[TBL] [Abstract][Full Text] [Related]
6. DJ-1 regulating PI3K-Nrf2 signaling plays a significant role in bibenzyl compound 20C-mediated neuroprotection against rotenone-induced oxidative insult.
Zhang XL; Yuan YH; Shao QH; Wang ZZ; Zhu CG; Shi JG; Ma KL; Yan X; Chen NH
Toxicol Lett; 2017 Apr; 271():74-83. PubMed ID: 28245986
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen-saturated saline mediated neuroprotection through autophagy via PI3K/AKT/mTOR pathway in early and medium stages of rotenone-induced Parkinson's disease rats.
Zhang Z; Sun X; Wang K; Yu Y; Zhang L; Zhang K; Gu J; Yuan X; Song G
Brain Res Bull; 2021 Jul; 172():1-13. PubMed ID: 33838212
[TBL] [Abstract][Full Text] [Related]
8. Geniposide protects against neurotoxicity in mouse models of rotenone-induced Parkinson's disease involving the mTOR and Nrf2 pathways.
Zhou Q; Chen B; Xu Y; Wang Y; He Z; Cai X; Qin Y; Ye J; Yang Y; Shen J; Cao P
J Ethnopharmacol; 2024 Jan; 318(Pt A):116914. PubMed ID: 37451492
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of secukinumab against rotenone induced Parkinson's disease in rat model: Involvement of IL-17, HMGB-1/TLR4 axis and BDNF/TrKB cascade.
Mohamed YT; Salama A; Rabie MA; Abd El Fattah MA
Int Immunopharmacol; 2023 Jan; 114():109571. PubMed ID: 36527875
[TBL] [Abstract][Full Text] [Related]
10. PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson's disease in rats.
Farid HA; Sayed RH; El-Shamarka ME; Abdel-Salam OME; El Sayed NS
Inflammopharmacology; 2024 Apr; 32(2):1421-1437. PubMed ID: 37541971
[TBL] [Abstract][Full Text] [Related]
11. Novel cudraisoflavone J derivatives as potent neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/HO-1 signaling.
Lu Q; Gouda NA; Quan G; Nada H; Elkamhawy A; Lee D; Lee CH; Cho J; Lee K
Eur J Med Chem; 2022 Nov; 242():114692. PubMed ID: 36029560
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic perspective of morin protection against ketoprofen-induced gastric mucosal injury: Targeting HMGB1/RAGE/NF-κB, DJ-1/Nrf2/HO-1 and PI3K/mTOR pathways.
Arab HH; Saad MA; El-Sahar AE; Al-Shorbagy MY
Arch Biochem Biophys; 2020 Oct; 693():108552. PubMed ID: 32860758
[TBL] [Abstract][Full Text] [Related]
14. Targeting ROS-Dependent AKT/GSK-3β/NF-κB and DJ-1/Nrf2 Pathways by Dapagliflozin Attenuates Neuronal Injury and Motor Dysfunction in Rotenone-Induced Parkinson's Disease Rat Model.
Arab HH; Safar MM; Shahin NN
ACS Chem Neurosci; 2021 Feb; 12(4):689-703. PubMed ID: 33543924
[TBL] [Abstract][Full Text] [Related]
15. Role of Nrf2/HO-1 and PI3K/Akt Genes in the Hepatoprotective Effect of Cilostazol.
Hassan M; Ibrahim MA; Hafez HM; Mohamed MZ; Zenhom NM; Abd Elghany HM
Curr Clin Pharmacol; 2019; 14(1):61-67. PubMed ID: 30179140
[TBL] [Abstract][Full Text] [Related]
16. Lignans from Eucommia ulmoides Oliver leaves exhibit neuroprotective effects via activation of the PI3K/Akt/GSK-3β/Nrf2 signaling pathways in H
Han R; Yu Y; Zhao K; Wei J; Hui Y; Gao JM
Phytomedicine; 2022 Jul; 101():154124. PubMed ID: 35487038
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effect of Ginsenoside Re against neurotoxin‑induced Parkinson's disease models via induction of Nrf2.
Qiao J; Zhao Y; Liu Y; Zhang S; Zhao W; Liu S; Liu M
Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35543148
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of biochanin A against rotenone-induced neurotoxicity in mice involves enhancing of PI3K/Akt/mTOR signaling and beclin-1 production.
El-Sherbeeny NA; Soliman N; Youssef AM; Abd El-Fadeal NM; El-Abaseri TB; Hashish AA; Abdelbasset WK; El-Saber Batiha G; Zaitone SA
Ecotoxicol Environ Saf; 2020 Dec; 205():111344. PubMed ID: 32977283
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson's Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk.
Shirgadwar SM; Kumar R; Preeti K; Khatri DK; Singh SB
J Alzheimers Dis; 2023; 94(s1):S109-S124. PubMed ID: 36463449
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of cordycepin on MPTP-induced Parkinson's disease mice via suppressing PI3K/AKT/mTOR and MAPK-mediated neuroinflammation.
Wang L; Tian S; Ruan S; Wei J; Wei S; Chen W; Hu H; Qin W; Li Y; Yuan H; Mao J; Xu Y; Xie J
Free Radic Biol Med; 2024 Apr; 216():60-77. PubMed ID: 38479634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
